BRIGHTSPRING INVESTOR DAY 29 79 145 38 154 188 141 198 63 213 133 18 200 200 200 143 143 143 70 184 218 Agenda March 17, 2026 1 Pharmacy Business Unit Overviews Specialty Pharmacy Infusion Pharmacy Home and Community Pharmacy The BrightSpring Platform Jon Rousseau, President and Chief Executive Officer Benito Fernandez, Chief Commercial Officer Robert Thomson, Chief Growth Officer Christopher Urban, RPh, Chief Operating Officer Rich Denness, President Scott Greenwell, PharmD, President Pharmacy Q&A Provider ...

Core Insights - Stoneridge reported a net loss of $76.9 million for Q4 2025, which includes a $16.7 million impairment of Control Devices assets and a $44.5 million tax valuation allowance [1][2] - The company achieved a 69% growth in MirrorEye sales, totaling $111 million in 2025, outperforming end-markets by 150 basis points [1][3] - For 2026, Stoneridge expects revenue guidance of $625 million to $650 million, with a midpoint of $638 million, representing a 4.2% growth compared to 2025 [1][2] Financial Performance - Q4 2025 sales were $205.2 million, with a gross profit of $33.2 million (16.2% of sales) and an adjusted EBITDA of $3.4 million (1.7% of sales) [1][2] - Full-year 2025 sales totaled $861.3 million, with a gross profit of $171.2 million (19.9% of sales) and an adjusted EBITDA of $25.0 million (2.9% of sales) [1][2] - The company reported a full-year net loss of $102.8 million, with an adjusted net loss of $31.9 million [1][2] Segment Performance - Electronics segment Q4 sales decreased by 10.8% to $133.2 million, primarily due to lower commercial vehicle production volumes [2][3] - Stoneridge Brazil's Q4 sales increased by 33.3% to $16.6 million, driven by OEM and aftermarket sales [2][3] - Control Devices segment Q4 sales increased by 2.0% to $64.4 million, attributed to higher passenger vehicle sales in North America and China [2][3] Cost Management - The company achieved an 80-basis point improvement in material costs and reduced quality-related costs by $6.6 million in 2025 [1][3] - Stoneridge expects to drive significant margin improvement through continued performance enhancements and structural cost reductions, targeting an adjusted EBITDA of $20 million to $25 million for 2026 [1][2] Future Outlook - For 2027, Stoneridge targets revenue of at least $715 million, driven by improving market conditions and continued growth in MirrorEye [1][3] - The company anticipates 2027 EBITDA of at least $44 million, with potential for further expansion through cost improvements [1][3] - Long-term targets include a revenue goal of $850 million to $1 billion by 2030, with an expected EBITDA margin of approximately 9.5% to 12.0% [3]

©2026 LIQUIDIA CORPORATION ALL RIGHTS RESERVED 2 Full Year 2025 Earnings & Corporate Update Liquidia Corporation March 5, 2026 ©2026 LIQUIDIA CORPORATION ALL RIGHTS RESERVED Forward-looking statements This presentation may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this presentation other than statements of historical facts, including statements regarding our future results of operations and financial position, o ...

Investor Presentation Fourth Quarter 2025 Kevin McAleenan Chief Executive Officer, Board Member Sean Ricker Chief Financial Officer © 2026 BigBear.ai, All rights reserved | BigBear.ai Proprietary. 1 Non-GAAP Financial Information This presentation includes financial measures that are not in accordance with generally accepted accounting principles ("GAAP"), such as EBITDA, Adjusted EBITDA, and Adjusted Gross Margin. We believe these non-GAAP financial measures provide investors and analysts with useful suppl ...

Core Insights - Ready Capital Corporation reported a GAAP loss per common share from continuing operations of $(1.46) and a distributable loss per common share of $(0.43) for the quarter ended December 31, 2025 [1][24] - The company is focusing on executing its liquidity plan to meet corporate obligations and reposition equity away from Covid-vintage production, which is expected to improve its liquidity profile and financial stability [2] Financial Performance - The company reported a net loss of $(232,612) thousand for the three months ended December 31, 2025, compared to a net loss of $(221,061) thousand for the same period in 2024 [11][24] - Total originations across all products reached $1.8 billion, with LMM commercial real estate originations at $235 million and Small Business Lending loan originations at $140 million [6] - The book value per share of common stock was $8.79 as of December 31, 2025 [6] Non-GAAP Financial Information - Distributable earnings, a non-GAAP measure, is defined as net income adjusted for various unrealized gains and losses, providing greater transparency into the company's financial performance [4][5] - The company reported a distributable loss before realized losses of $(10,070) thousand for the quarter, leading to a total distributable loss of $(65,279) thousand [11] Subsequent Events - The company completed the acquisition of United Development Funding IV, a real estate investment trust, and sold its Residential Mortgage Banking business, GMFS [6] - The company also secured ownership of a mixed-use asset in Portland, OR, and retired the remaining outstanding amount on a 5.75% Senior Unsecured Note due February 2026 [6] Segment Reporting - For the three months ended December 31, 2025, the LMM Commercial Real Estate segment reported a net interest loss after provision for loan losses of $(140,572) thousand, while the Small Business Lending segment reported a net interest income of $3,705 thousand [26] - Total non-interest expense for the consolidated entity was $(100,049) thousand for the quarter [27]

Fourth Quarter and Full Year 2025 Earnings February 18, 2026 Safe Harbor Statement These materials include projections and other forward-looking statements regarding Garmin Ltd. and its business that are commonly identified by words such as "anticipates," "would," "may," "expects," "estimates," "plans," "intends," "projects," and other words or phrases with similar meanings. Any statements regarding the Company's expected fiscal 2026 GAAP and pro forma estimated earnings, EPS, and effective tax rate, and th ...

Fourth Quarter and FY2025 Preliminary and Unaudited Results February 10, 2026 Forward-Looking Statements and Risk Factors Certain statements in this presentation are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, particularly those regarding our 2025 Financial Guidance. Such forward-looking statements are subject to numerous assumptions, risks and uncertainties that could cause actual results to differ materially from those described in those stateme ...

Core Insights - Under Armour reported a third-quarter revenue decrease of 5% to $1.33 billion, with a 10% decline in North America and a 3% increase in international revenue [6][10]. - The company experienced an operating loss of $150 million, with adjusted operating income of $26 million after excluding certain expenses [6][10]. - The CEO expressed optimism about the company's transformation and brand momentum, indicating that the December quarter marked a challenging phase but expects greater stability moving forward [2][6]. Financial Performance - Revenue decreased 5% to $1.33 billion, with North America revenue down 10% to $757 million and international revenue up 3% to $577 million [6][10]. - Gross margin declined by 310 basis points to 44.4%, primarily due to higher tariffs and pricing headwinds [6][10]. - Selling, general and administrative (SG&A) expenses increased 4% to $665 million, but adjusted SG&A declined 7% to $563 million when excluding litigation and transformation expenses [6][10]. Restructuring and Transformation - The company is undergoing a restructuring plan expected to cost up to $255 million, with $178 million recorded in restructuring and impairment charges to date [7][10]. - The restructuring plan aims to improve financial and operational efficiency, with a focus on better products and disciplined market presence [2][7]. Outlook - For fiscal 2026, revenue is expected to decline approximately 4%, with a projected operating loss of around $154 million [10]. - Adjusted diluted earnings per share are anticipated to range from $0.10 to $0.11, compared to a previous outlook of $0.03 to $0.05 [10]. Inventory and Liquidity - Inventory decreased by 2% to $1.1 billion, indicating improved inventory management [6][10]. - Cash and cash equivalents totaled $465 million at quarter-end, with no borrowings under the $1.1 billion revolving credit facility [6][10].

Benchmark Electronics Fourth Quarter and Fiscal Year 2025 Results February 3rd, 2026 Forward-Looking Statements This document contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are identified as any statement that does not relate strictly to historical or current facts and may include words such as "anticipate," "believe," "intend," "plan," "projec ...

Business Overview - Concentra is the largest provider of occupational health services in the United States by number of locations[7] - The company cares for an average of over 52,000 patients each business day[7] - Concentra serves approximately 200,000 employer customers[7] - The company treats approximately 1 in every 4 injuries that occur within the U S workplace[12] - Concentra has over 1,000 total locations[12] Financial Performance - Concentra's TTM Revenue is $21 billion[8] - The company's TTM Adjusted EBITDA is $414 million[8] - Concentra's TTM Adjusted EBITDA margin is 198%[8] - The company's TTM free cash flow is $176 million[11] - Concentra's revenue from the largest employer customer is less than 3%[8]